Use of domperidone as a galactagogue drug: A systematic review of the benefit-risk ratio

Journal of Human Lactation

Volumn 31, Issue 1, 2015, Pages 57-63

  Paul, Catherine ^a   Zénut, Marie ^a,b   Dorut, Agnès ^b   Coudoré, Marie Ange ^a,b   Vein, Julie ^c   Cardot, Jean Michel ^a,b   Balayssac, David ^b,c  

^a UNIVERSITÉ CLERMONT AUVERGNE   (France)

^b UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

^c Université d'Auvergne ^*  (France)

Author keywords

benefit risk ratio; breastfeeding; domperidone

Indexed keywords

DOMPERIDONE; GALACTOGOGUE;

BREAST FEEDING; BREAST MILK; DRUG EFFECTS; FEMALE; HUMAN; NEWBORN; RISK ASSESSMENT;

BREAST FEEDING; DOMPERIDONE; FEMALE; GALACTOGOGUES; HUMANS; INFANT, NEWBORN; MILK, HUMAN; RISK ASSESSMENT;

EID: 84920964488     PISSN: 08903344     EISSN: 15525732     Source Type: Journal    
DOI: 10.1177/0890334414561265     Document Type: Review

References (31)

1. Hill PD, Aldag JC, Chatterton RT, Zinaman M. Comparison of milk output between mothers of preterm and term infants: the first 6 weeks after birth. J Hum Lact. 2005 ; 21 (1). 22-30
2. Amir LH. Breastfeeding - managing "supply" difficulties. Aust Fam Physician. 2006 ; 35 (9). 686-689
3. Anderson PO, Valdés V. A critical review of pharmaceutical galactagogues. Breastfeed Med. 2007 ; 2 (4). 229-242
4. Grzeskowiak LE, Lim SW, Thomas AE, Ritchie U, Gordon AL. Audit of domperidone use as a galactogogue at an Australian tertiary teaching hospital. J Hum Lact. 2013 ; 29 (1). 32-37
5. Barone JA. Domperidone: a peripherally acting dopamine2-receptor antagonist. Ann Pharmacother. 1999 ; 33 (4). 429-440
6. Ahmad N, Keith-Ferris J, Gooden E, Abell T. Making a case for domperidone in the treatment of gastrointestinal motility disorders. Curr Opin Pharmacol. 2006 ; 6 (6). 571-576
7. Reddymasu SC, Soykan I, McCallum RW. Domperidone: review of pharmacology and clinical applications in gastroenterology. Am J Gastroenterol. 2007 ; 102 (9). 2036-2045
8. Agence Nationale de Sécurité du Médicament et des produits de Santé. Résumé des caractéristiques du produit - Domperidone Motilium 10 mg, comprimé pelliculé. Saint Denis, France: Agence Nationale de Sécurité du Médicament et des produits de Santé; 2011. http://agence-prd.ansm.sante.fr/php/ecodex/frames.php?specid=63679194&typedoc=R&ref=R0186787.htm. Accessed December 18, 2013.
9. Ward BA, Morocho A, Kandil A, Galinsky RE, Flockhart DA, Desta Z. Characterization of human cytochrome P450 enzymes catalyzing domperidone N-dealkylation and hydroxylation in vitro. Br J Clin Pharmacol. 2004 ; 58 (3). 277-287
10. Hofmeyr GJ, van Iddekinge B. Domperidone and lactation. Lancet. 1983 ; 1 (8325). 647
11. Caron MG, Beaulieu M, Raymond V, et al. Dopaminergic receptors in the anterior pituitary gland. Correlation of [3H]dihydroergocryptine binding with the dopaminergic control of prolactin release. J Biol Chem. 1978 ; 253 (7). 2244-2253
12. Campbell-Yeo ML, Allen AC, Joseph KS, et al. Effect of domperidone on the composition of preterm human breast milk. Pediatrics. 2010 ; 125 (1). e107 - e114
13. Wan EW-X, Davey K, Page-Sharp M, Hartmann PE, Simmer K, Ilett KF. Dose-effect study of domperidone as a galactagogue in preterm mothers with insufficient milk supply, and its transfer into milk. Br J Clin Pharmacol. 2008 ; 66 (2). 283-289
14. Donovan TJ, Buchanan K. Medications for increasing milk supply in mothers expressing breastmilk for their preterm hospitalised infants. Cochrane Database Syst Rev. 2012 ; 3 :
15. Osadchy A, Moretti ME, Koren G. Effect of domperidone on insufficient lactation in puerperal women: a systematic review and meta-analysis of randomized controlled trials. Obstet Gynecol Int. 2012 ; 2012: 642893
16. Knoppert DC, Page A, Warren J, et al. The effect of two different domperidone doses on maternal milk production. J Hum Lact. 2013 ; 29 (1). 38-44
17. Ingram J, Taylor H, Churchill C, Pike A, Greenwood R. Metoclopramide or domperidone for increasing maternal breast milk output: a randomised controlled trial. Arch Dis Child Fetal Neonatal Ed. 2012 ; 97 (4). F241 - F245
18. Da Silva OP, Knoppert DC, Angelini MM, Forret PA. Effect of domperidone on milk production in mothers of premature newborns: a randomized, double-blind, placebo-controlled trial. Can Med Assoc J. 2001 ; 164 (1). 17-21
19. Petraglia F, De Leo V, Sardelli S, Pieroni ML, D'Antona N, Genazzani AR. Domperidone in defective and insufficient lactation. Eur J Obstet Gynecol Reprod Biol. 1985 ; 19 (5). 281-287
20. Jantarasaengaram S, Sreewapa P. Effects of domperidone on augmentation of lactation following cesarean delivery at full term. Int J Gynaecol Obstet. 2012 ; 116 (3). 240-243
21. Asztalos EV, Campbell-Yeo M, Da Silva OP, Kiss A, Knoppert DC, Ito S. Enhancing breast milk production with Domperidone in mothers of preterm neonates (EMPOWER trial). BMC Pregnancy Childbirth. 2012 ; 12: 87
22. Centre de médecine familiale Herzl, Clinique d'allaitement Goldfarb, Hôpital général juif. Dompéridone - Document à l'intention des patients. Montréal, Canada; 2012. http://www.jgh.ca/documents/95/Domperidone-doc%20pour%20patients%202012.pdf. Accessed January 9, 2014.
23. NewmanJ. Domperidone. Canadian Breastfeeding Foundation;2005. http://www.canadianbreastfeedingfoundation.org/induced/domperidone.shtml. Accessed January 9, 2014.
24. Hofmeyr GJ, Van Iddekinge B, Blott JA. Domperidone: secretion in breast milk and effect on puerperal prolactin levels. Br J Obstet Gynaecol. 1985 ; 92 (2). 141-144
25. Hale TW Medications and Mothers' Milk 2012. 2012. 15th ed.Amarillo, TX: Hale Publishing; 2012. Amarillo, TX: Hale Publishing ; 2012 :
26. Gremmo-Féger G, Dobrzynski M, Collet M. Allaitement maternel et médicaments. J Gynecol Obstet Biol Reprod. 2003 ; 32 (5). 466-475
27. Begg EJ, Duffull SB, Hackett LP, Ilett KF. Studying drugs in human milk: time to unify the approach. J Hum Lact. 2002 ; 18 (4). 323-332
28. Hondeghem LM. Domperidone: limited benefits with significant risk for sudden cardiac death. J Cardiovasc Pharmacol. 2013 ; 61 (3). 218-225
29. van Noord C, Dieleman JP, van Herpen G, Verhamme K, Sturkenboom MC. Domperidone and ventricular arrhythmia or sudden cardiac death: a population-based case-control study in the Netherlands. Drug Saf. 2010 ; 33 (11). 1003-1014
30. Michaud V, Turgeon J. Domperidone and sudden cardiac death: how much longer should we wait?. J Cardiovasc Pharmacol. 2013 ; 61 (3). 215-217
31. Balayssac D, Authier N, Cayre A, Coudore F. Does inhibition of P-glycoprotein lead to drug-drug interactions?. Toxicol Lett. 2005 ; 156 (3). 319-329